Review
Antibiotic resistance among clinically important Gram-positive bacteria in the UK

https://doi.org/10.1016/S0195-6701(98)90020-2Get rights and content

Abstract

The resistance of bacteria to antibiotics, particularly those used for first-line therapy, is an increasing cause for concern. In the UK, the prevalence of resistance to methicillin and mupirocin in Staphylococcus aureus, and to penicillin and macrolides in Streptococcus pneumoniae, appear to be increasing. There has also been an increase in the number of hospitals where glycopeptide-resistant enterococci are known to have been isolated. The increases in methicillin-resistant S. aureus and glycopeptide-resistant enterococci are due, in part, to the inter-hospital spread of epidemic strains. Although new quinolones and streptogramins with activity against Gram-positive bacteria (including strains resistant to currently available agents) are under development, there is no reason to believe that resistance to these agents will not emerge. The control of resistance in Gram-positive bacteria will require a multi-faceted approach, including continued and improved surveillance, a reduction in the unnecessary use of antibiotics, and the application of other strategies such as vaccination.

References (77)

  • PD Meers et al.

    Multiply-resistant pneumococcus

    Lancet

    (1978)
  • DC Shanson et al.

    Ear infection due to penicillin-resistant pneumococcus in immunodeficient child

    Lancet

    (1979)
  • TCJ Boswell et al.

    Antibiotic resistance and serotypes of Streptococcus pneumoniae at Birmingham Public Health Laboratory, 1989-94

    J Infect

    (1996)
  • EJ Ridgway et al.

    Penicillin-resistant pneumococci in a Merseyside hospital

    J Hosp Infect

    (1991)
  • K Klugman et al.

    The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci

    Clin Microbiol Infect

    (1997)
  • AHC Uttley et al.

    Vancomycin-resistant enterococci

    Lancet

    (1988)
  • TR Frieden et al.

    Emergence of vancomycin-resistant enterococci in New York City

    Lancet

    (1993)
  • CW Ford et al.

    Oxazolidinones: New antibacterial agents

    Trends Microbiol

    (1997)
  • N Woodford et al.

    Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci

    Lancet

    (1997)
  • A Tomasz
  • RR Marples et al.

    Methicillin-resistant Staphylococcus aureus in England and Wales

    CDR Rev

    (1992)
  • HF Chambers

    Methicillin resistance in staphylococci: Molecular and biochemical basis and clinical implications

    Clin Microbiol Rev

    (1997)
  • Epidemic methicillin resistant Staphylococcus aureus

    CDR

    (1997)
  • G Duckworth et al.

    Guidelines on the control of methicillin-resistant Staphylococcus aureus in the community

    J Hosp Infect

    (1995)
  • RR Marples et al.

    Prevalence of mupirocin resistance in Staphylococcus aureus

    J Hosp Infect

    (1995)
  • N Woodford et al.

    Current perspectives on glycopeptide resistance

    Clin Microbiol Rev

    (1995)
  • K Hiramatsu et al.

    Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility

    J Antiniicrob Chemother

    (1997)
  • Staphylococcus aureus with reduced susceptibility to vancomycin—United States, 1997

    Morbid Mortal Weekly Rep

    (1997)
  • Detecting vancomycin intermediate Staphylococcus aureus

    CDR

    (1997)
  • F Baquero

    Gram-positive resistance: challenges for the development of new antibiotics

    J Antimicrob Chemother

    (1997)
  • JM Andrews et al.

    Surveillance of Gram positive pathogens in the UK (1996)

  • FW Goldstein et al.

    Percentages and distributions of teicoplanin-and vancomycin-resistant strains among coagulase-negative staphylococci

    Antimicrob Agents Chemother

    (1990)
  • JW Kislak et al.

    Susceptibility of pneumococci to nine antibiotics

    Am J Med Sci

    (1965)
  • VJ Howes et al.

    Meningitis due to a relatively penicillin-resistant pneumococcus

    Br Med J

    (1976)
  • AP Johnson et al.

    Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995

    Br Med J

    (1996)
  • OM Aszkenasy et al.

    Pneumococcal bacteraemia and meningitis in England and Wales 1982 to 1992

    CDR Rev

    (1995)
  • Antimicrobial resistance of pneumococci isolated from blood and cerebrospinal fluid 1993 and 1994

    CDR

    (1995)
  • H Laurichesse et al.

    Pneumococcal bacteraemia and meningitis in England and Wales, 1993–1995

    Comm Dis Publ Hlth

    (1998)
  • Cited by (46)

    • Implementation and outcomes of hospital-wide computerized antimicrobial approval system and on-the-spot education in a traumatic intensive care unit in Taiwan

      2018, Journal of Microbiology, Immunology and Infection
      Citation Excerpt :

      In ICUs, inappropriate antibiotic usage was higher in patients undergoing surgery,5 while 5%–57% of patients develop nosocomial infections.7,11 Multidrug resistant (MDR) bacteria, both gram positive cocci and gram negative bacilli (GNB), are increasingly widespread processes in hospital settings.12,13 The hospital-wide computerized antimicrobial approval system (HCAAS) was developed in September 2004 at Chang-Gung Memorial Hospital (CGMH), and the implementation of an online antibiotic control program was first reported at CGMH-Taoyuan in Taiwan in 2011.14

    • Minimising moxifloxacin resistance with tuberculosis

      2008, The Lancet Infectious Diseases
    • Rhys-davies exsanguinator: a haven for bacteria

      2007, Journal of Hand Surgery: European Volume
    View all citing articles on Scopus
    View full text